News | Computed Tomography (CT) | June 14, 2018

Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT

Hospital installs portable 32-slice CT in brachytherapy suite for treatment planning

Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT

June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that Florida Hospital in Orlando, Fla., added the BodyTom Elite computed tomography (CT) scanner to their brachytherapy suite.

The portable, 32-slice BodyTom Elite improves the patient experience, patient safety and workflow efficiency by eliminating the need to transfer patients. The scanner increases the volume the department can take on while decreasing operating room time by allowing patient repositioning to occur in the operating room (OR). Real-time imaging enhances accuracy when treating cancer patients undergoing brachytherapy treatment.

“Introducing a 32-slice CT scanner has improved our imaging quality and our post-scan reconstruction capabilities, which has helped us deliver our patients higher quality care,” said Matthew Biagioli, M.D., board certified radiation oncologist at Florida Hospital. “Looking forward, the addition of the BodyTom Elite will allow us to accommodate a higher volume of patients in our brachytherapy suite.”

The recently upgraded BodyTom Elite incorporates a new visual design, upgraded software including improved noise- and metal-artifact reduction, along with multiple hardware enhancements. The system remains a self-shielded, multi-departmental imaging solution capable of transforming any room in the hospital to an advanced imaging suite.

In brachytherapy suites, radiation oncologists treat forms of prostate, lung, breast, colorectal and gynecologic cancers by temporarily inserting radioactive sources inside tumors or surrounding areas. This process enables precise delivery of high doses in a short time. Adopting a BodyTom Elite at the head of any brachytherapy suite allows the position of an after-loading device to be verified all in one room while the patient remains unmoved. By removing the need to transfer the patient to an additional diagnostic CT suite, overall patient satisfaction and safety will be significantly improved.

For more information: www.neurologica.com

Related Content

In the light of the coronavirus outbreak, MILabs has enhanced its line of high-performance CT scanners to even better detect the disease #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Computed Tomography (CT) | March 27, 2020
March 27, 2020 — Based on recent scientific research, diagnostic X-ray...
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Series CT scans in 35-year-old woman with COVID-19 pneumonia. (a) Scan obtained on illness days 1 showed multiple pure ground-glass opacity (GGO) mainly in right lower lobe. (b) Scan obtained on illness days 5 showed increased extent of GGO and early consolidation. (c) Scan obtained on illness days 11 showed multiple consolidation with almost the same extent. (d) Scan obtained on illness days 15 showed a mixed pattern with a slightly smaller extent, and the perilobular consolidation might suggest the presence of organizing pneumonia. The patient was discharged on illness days 17. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — In a new study pub
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | March 19, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new